chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported she felt "electric zaps" all throughout her body periodically over 24 hours. These zaps started within 24 hours of her receiving the vaccine per patient.
Day 6 after receiving vaccine, slightly swollen and sore left axilla nodes.  Day 8 starting to resolve
Moderna COVID-19 Vaccine EUA  04/28/2021 0925: Vaccination given 1000: Tylenol (1000mg) 2030: Noticed arm was sore at vacc spot 2105: Tylenol (1000mg) 2350: Started getting chills 04/29/2021 0030: Extreme chills, no apparent fever (temp: 98.7F) 0120: Lower back pain - felt similar to when I had a kidney stone. (About a 5 to 6) Passed some gas, but no relief 0134: Lower abdominal pain, like bad gas (About a 3 to 4) 0142: Lower back and abdominal pain subsiding 0150: Lower back and abdominal pain resolved 0157: Whole body aches;  malaise  If I remove the heavy coat keeping me warm, I get chilled quickly.
incidence of flu like symptoms after vaccination; This case was reported by a other health professional via call center representative and described the occurrence of influenza-like symptoms in an unspecified number of male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Bexsero.  Additional case details were reported as follows: The age at vaccination was not applicable for this report. The reporter mentioned an incidence of flu like symptoms in boys after Meningococcal B vaccination. When the office sees this, the reporter did not complete the series. The reporter consented to follow up.
Got the shot around noon on Friday, At midnight that same day. woken up out of a sound sleep with very loud ringing in right ear (thought my fire alarm was going off).  By that morning it was not as loud but still always present high pitched ringing that sometimes pulses and an ear ache.  Went to CVS minute clinic on Monday. Said inner ear was inflamed and had some fluid. Prescribed  amoxicillin. No change yet except ringing has also given me a headache.
Chills began within 11 hours. The following morning I was exhausted and weak, nauseated, headache, eye pain, right ear pain, injection site pink, puffy, and sore, felt faint when I got up to the bathroom. I reached the recliner, my husband helped take my blood pressure: 85/40, Pulse 55. I called 911 and was taken to the ER and treated with 1000cc Normal Saline, Tylenol 650 mg, and Ondansetron ODT 4 mg. EKG showed 2 PVC's which I have not had before. I was released about 2 hours later. I felt weak, nausea, and headache until 11 pm. No problems since 9am 2/17/2021.
Patient received Hepatitis B vaccine on the morning of 3/18/15 at our clinic. She reports she went to the grocery store shortly after and about 30 minutes after receiving vaccine she began shaking vigorously, she felt very cold, and developed a severe headache.   Patient presented to our clinic with this symptoms. Vitals all within normal limits. 1000 mg of Tylenol were administered to patient orally. Symptoms subsided within an hour.
By afternoon, I had horrible fatigue -worse than I have ever had. Headache that lasted for days and days and days - lasted for almost three weeks. My blood pressure was spiking that first night, too. - they had to put me on Propranolol to keep it down. Usually we have to help me blood pressure go up. I finally went to see the doctor when the headache wasn't going away.  The propranolol helped the BP to go down but even with all the meds I could take the headache was still persisting.
Severe menstrual cramping -doubled over, crying, in pain, vomiting, heat sensitive and light sensitive, dizziness.
In about 3-4 wks post vaccine administration, developed right sided numbness/ loss of sensitivity of right torso. MRI revealed multiple brain lesions and one enhancing spine lesion. Diagnostic tests: lab work ruled out defficiencies, Lyme disease, HIV, Thyroid abnormalities. Lumbar puncture/ CSF showed positive IgG index, increased WBCs. Subsequently Left leg numbness/ loss of sensation developed. Received course of intravenous steroids. Evoked potential showed abnormality of left lower extremity. 2-nd MRI in one month demonstrated multiple brain lesions the new second spine lesion. Received second course of intravenous steroids. Started on Rebif injections SQ. Developed Mitral Valve Prolapse. Per telephone f/u with patient on 7/28/05, additional symptoms included nausea, fatigue, and memory loss. Per review of medical records on 7/28/05, final diagnosis was multiple sclerosis and additional symptom of headache was noted. Follow up on 7/12/05: Numbness, tingling, electric current at left side, fatigue, headache, memory problems. Prior to receiving this Hep B vaccine, I was a completely healthy individual. Had no contributing factors or family history for developing demyelinating disease.
This case was reported by a consumer (subject) and described the occurrence of swollen salivary glands in a 39-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included allergy to ibuprofen, allergy to NEXIUM, allergy to PRILOSEC, codeine allergy and cold. Concurrent medications included Vitamins. On 24 October 2011 the subject received a dose of FLUARIX (.5 ml, unknown route, left arm). In 2011, about 2 weeks after vaccination with FLUARIX, the subject experienced swollen salivary glands, lymphadenopathy, pain and infection. The subject reported receiving FLUARIX and developing swollen salivary glands "under her chin" about 2 weeks after vaccination. The subject reported having pain and that when she went to the doctor, "it was called lymphadenopathy". The subject was treated with a course of antibiotics. "It was assumed she had an infection since she had pain". She indicated the swelling [of the salivary gland] was "like a golf ball". She reported she had a cold at the time of vaccination. In 2011, the events were resolved about 5-6 days after starting the antibiotics. The subject reported events after her 2012-13 FLUARIX also (rechallenged and events recurred). See case A1002313B for details regarding this case.
Multiform, extremely pruritic red, raised rash. wheals ,angio edema Initially thought to be scabies and treated for 2 weeks PHCP referred to Dermatologist referred to Allergist  Started Tx's:  Permetherin - 2 courses, approximately 4.15.21 Prednisone x 12 days,  Kenalog 40 IM by Dermatologist then Pepcid, Zyrtec, Singular, Hydroxyzine, Kenalog Cream- no long-lasting relief  Pepcid, Zyrtec, Hydroxyzine- doses doubled  - by Allergist
Early afternoon, my arm felt sore, warm and tight. I was wearing a long sleeved top.  When I looked, the area was pink, raised, with hard lump a few inches below the injection site (which was still bruised). Entire area was pink,  hard and warm to the touch. In the center of the pink area for a red spot.  There was a noticeable  pink line about 2-3 inches long from the injection site to the pink area. I look my temperature, it was 97.7 I put a cool compress on the site and took Tylenol
I have been very dizzy the entire time since the shot and i keep tasting copper in my mouth?
Rash that occurred on bilateral arms. EMS was on standby and assessed patient. EKG normal. No medications provided.
Screamed for 6 hrs p/vax. Rec'd Tylenol q 4 hrs.
Patient was admitted to Hospital on 11/15/2021 for COVID related symptoms. This is considered a breakthrough case.
My son cried with DTaP. The second he did not and the third he did not. He became hypotonic and constipated right after 3rd shot. He screamed for hours each day. I was told it was colic. He was 5 months old. Too old for colic. The MD lost his lot number and I signed no consent form. He did give him the vaccine containing thimersol. PDD-NOS, sensory integration disorder, vision problems and still hyptonic.  Mother believe whatever happened started w first DTaP. He cried. By the shot he was not progressing pain. Third shot again no crying, 2nd DTaP. Hypotonic- lost strength in movement. Like a sponge. Never expressed differnt emotions. Starting licking left leg only- result never mind. A 60-day follow up report received 6/23/2003 adds: (from mother) My child still has hypotonia (low muscle tone) expressive and receptive language disabilities. Clumsy movements. On autistic spectrum (PDD). Learning disabilities. Possible mental retardation. My child was fine for his 1st shot. He cried. Very engaging baby beginning to roll over. Full term - 11 lbs at birth. 2nd shot-no crying. 3rd shot-no crying on administration-became constiipated for days after shot. Cried every days for 5-6 hours straight for over a month to 2 months at least. Dr lied and said my son received no thimerosol (said it was colic). He never kept lot numbers (which is a law) I still can't get paper trail. I have filed with the State of PA to get help in retrieving this info. Our life and my son's life and our daughters' lives have been changed forever. This should have never happened. Thank you.  Annual follow up on 04/21/04: "Pt has not recovered from adverse event.  My son has been diagnosed with autism.  He has high mercury levels in his system which came from the thimerosal.  He has speech and language impairment.  Sensory integration and has high titers to Polio vaccine.  1-32 is normal range his is 320!! The Dr. lied to me about being mercury free.  My son lost his muscle tone after shot, screamed constantly became constipated and then had diarrhea for almost 1 and half years.  Afterwards, the Dr. never kept lot #'s which is a law! He said he lost them on a slip of paper.  My son struggles everyday to speak and do things, which should come naturally to him.  What an injustice to him.  Thank you."
liver damage; liver damage; Jaundice; Jaundice; Liver Blockage; Eyes are Yellow; UTI; Liver Enzymes are Worse than when she took Tylenol; This is a spontaneous report from a contactable consumer (spouse). A 42-year-old female patient (Reporter's Wife) received bnt162b2 (COMIRNATY, Covid 19 Vaccine, mRNA), dose 2 via an unspecified route of administration at the end of Apr2021 (Batch/Lot number was not reported) as dose 2, single at the age of 41-year-old for COVID-19 immunisation. No medical history. Concomitant medications were not reported. Historic vaccine was bnt162b2 received via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as dose 1, single at the age of 41-year-old for COVID-19 immunisation. The patient previously took tylenol in 2019 and not ongoing for blood clot and experienced liver damage with jaundice. No additional vaccines administered on same date of the Pfizer suspect. This report is not related to a study or programme. No prior vaccinations (within 4 weeks). Family medical history relevant to AEs: Not that they are aware of. The patient experienced liver damage, liver blockage, jaundice, eyes are yellow, urinary tract infection, liver enzymes were worse than when she took Tylenol in Aug2021. The patient was hospitalized for the events from 26Aug2021 and ongoing. Events resulted in emergency room and physician office visit. 2 years ago the patient had blood clot and had taken Tylenol. She had liver damage with jaundice. She stopped taking Tylenol and so the jaundice went away and she was back to normal. The patient was now in the ER with the same symptoms as when she took Tylenol. Stated that she was back in the hospital because liver damage again. Her husband was trying to figure out why her liver had been damaged, the last thing that she took was only the Pfizer Covid 19 vaccine. Asking if in Pfizer Covid 19 vaccine has an ingredient that Tylenol has. The patient took second shot at the end of April2021. She had a reaction to Tylenol sometime back and it attacked her liver and she was doing okay and then after the second shot her enzymes are worse than when she took the Tylenol. Caller was wondering if she took some type of Tylenol that was in the vaccine or something that triggered her reaction? Caller stated it was a long shot but he wasn't sure if there was something that is in Tylenol that is in the ingredients of the Covid vaccine? Caller stated the doctors automatically said no but he can't rule it out until he checks it out. Lab tests on Aug2021: bloodwork, MRI last night, biopsy today or Monday, urine sample found out UTI. Caller stated the MRI showed the blockage in her liver. The patient got her blood results and went to the ER immediately. The patient felt fine and she did the last time. This is the same as when the said to quit taking Tylenol. It was extra strength Tylenol for a blood clot in 2019. UPC, Lot, Expiration: Unknown. The outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Inappropriate schedule of vaccine administered; VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT; VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT; VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered), VACCINATION SITE PRURITUS (VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT), VACCINATION SITE RASH (VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT) and VACCINATION SITE PAPULE (VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered), VACCINATION SITE PRURITUS (VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT), VACCINATION SITE RASH (VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT) and VACCINATION SITE PAPULE (VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered), VACCINATION SITE PRURITUS (VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT), VACCINATION SITE RASH (VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT) and VACCINATION SITE PAPULE (VACCINE SITE RATION/ SMAL RASH RAISED A LITTLE ITCHY ON RIGHT SIDE MORE THAN LEFT) outcome was unknown.            Concomitant drug was not reported. Treatment details were not reported.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Pt is still having moderate pain at the left upper arm and left shoulder joint ever since he got the injection.  He has moderate limited range of motion still since the injection of the Covid Vaccine.
This spontaneous report as received from a medical assistant, refers to an unspecified number of patients whose age and gender was not specified. The patient's pertinent medical history, and drug reactions or allergies information, if any, were not provided. Concomitant therapies administered to them included sterile diluent (STERILE DILUENT). From 25-MAY-2018 until 04-JUN-2018, the unspecified amount of patients were vaccinated with improperly stored VARIVAX (lot numbers N031001 [expiration date 03-NOV-2019], N035937 [expiration date 18-DEC-2019], and N03001 [expiration date 03-NOV-2019]) for prophylaxis (dose, dose number, frequency, route and anatomical location of administration were not reported); and PROQUAD recombinant Human albumin (rHA) (lot number R001541, expiration date 15-JUL-2019), subcutaneously, for prophylaxis (dose, dose number, frequency, anatomical location of administration were not reported). The doses of VARIVAX and PROQUAD were exposed to a temperature excursion of 6 degrees Fahrenheit (°F) to 14°F (also reported as "9F") for a time frame of 10 minutes; and of 15°F to 46°F (also reported as "25F") for 20 minutes. The temperature excursion was not detected by the Digital Data Logger. There was no previous temperature excursion either. The nurse reported that the sterile diluent (STERILE DILUENT) (lot number R010529, 05-DEC-2018) used to reconstitute the vaccines was properly stored. No adverse effects or product quality complaints were reported. Further information was not provided. Lot number N03001 is an invalid lot number for varicella virus vaccine live (oka/merck). This case has been considered non-valid, since patient identifiers were not provided by the reporter. Follow-up information has been received from the medical assistant on 17-JUL-2018. Upon receipt of follow-up, the case has become valid from non-valid due to patient identifiers. Reporter clarified that this report refers to 12 months old female patient. On 10-JUL-2018, the patient was vaccinated with improperly stored doses of VARIVAX (dose, units and frequency not reported) (lot# N035937 and expiration date: 18-DEC-2019), subcutaneously. This is one of the multiple reports received from the same reporter.; Sender's Comments: US-009507513-1807USA009247: US-009507513-1807USA009246: US-009507513-1807USA009245: US-009507513-1807USA009241: US-009507513-1807USA009243: US-009507513-1807USA009242: US-009507513-1807USA009244:
Patient presented in dermatology office on 2/24/2021 with a 24 hour history of a rapidly progressing, generalized pruritic maculopapular and confluent erythematous rash primarily over torso and proximal upper extremity. She was treated with oral fexofenadine, prednisone 5 mg bid for 6 days, cool compresses, and emollients. Follow up 3/1/2021 showed approximately 60% resolution of the rash.  Topical triamcinolone cream was added to therapy.
She complained of redness and pain in her arm. After it continued for several day she went to the doctor where they said she had an infection along with an ear infection. She was given an antibiotic and an ear drop.
Having a hard time breathing; achy; head ache; sweats; This is a spontaneous report from a contactable nurse (patient). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and expiration date were not reported), via an unspecified route of administration, administered in the left arm on 27Feb2021 13:00 (at the age of 53-years-old) as second dose, single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included estradiol, sertraline and levothyroxine; all taken for an unspecified indication, start and stop dates were not reported. The patient previously took erythromycin and experienced drug allergy. The patient was previously vaccinated with the first dose of BNT162B2 for COVID-19 immunisation. The patient was not pregnant. The patient had no COVID prior to vaccination. The patient has been tested for COVID post vaccination. No other vaccine was given to the patient in four weeks. On 28Feb2021 02:00, the patient experienced having a hard time breathing, achy, head ache and sweats. The events were reported as non-serious. No treatment was given for the events. The patient underwent lab tests and procedures which included nasal swab (nasopharyngeal) (SARS-CoV-2 test): negative on 22Feb2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Administered vaccine. Immediately pt did bleed and hematoma developed just above the injection site.
Patient was vaccinated on 07MAR21 @ 1830 and returned to the vaccine room on 14MAR21 @ 0430 complaining of injection site (left deltoid) swelling and redness.  She was evaluated by one of our registered nurses who noted a pronounced red rash on bilateral arms.  She was offered a Benadryl but denied a Benadryl while onsite.  She stated that she would "just go home and take my allergy medicine at home."  She is to follow-up with our onsite nurse as needed.
first dose/ December 2020/did not have records/  received the second dose.; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 61-year-old patient who received HBV (Engerix B adult) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B adult (received first dose in December 2020 with batch number 2224m and expiry date 1st March 2022).   On an unknown date, the patient received the 2nd dose of Engerix B adult and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at the vaccination was not applicable for this report. The Nurse Practitioner reported that till the time of reporting, the patient did not receive second dose of Engerix B adult, which led to incomplete course of vaccination. The reporter did not have records that the patient has received the second dose. No further information was provided. The vaccine administration facility was the same as primary reporter. The reporter did not consented to follow up.
Patient had her immunizations on 7/30/2020. She states that a few hours after her immunizations were given she began to have problems moving her right arm. She states her left arm never gave her immobility issues.  She states that the her arm also hurt on the right side. Left side was fine. Patient states that she ran a fever of 100 for 2 days. She states that as time went on she could not move her arm at all. Patient did go to walk in clinic on 8/4/2020. She also report the symptoms to her PCP on 8/04/2020. Patient continued to have the symptoms with slight improvement and again reported on 8/6/2020. Patient states that she was able to move her arm but still was not 100%. She was told to call the clinic in a couple of days if not resolved. Pt will be having further testing as she is still having symptoms. Her left arm remains fine with no issues.